Scottish Radiological Society Spring Meeting 2021 May 14, 2021 09:00 AM - 05:00 PM — Virtual Meeting (online)
9th Annual Scottish Radiotherapy Research Forum Jun 03, 2021 12:30 PM - 05:00 PM — Virtual Meeting (online)
Medical Imaging Convention [rescheduled] Sep 15, 2021 - Sep 16, 2021 — National Exhibition Centre, Birmingham, England
Total Body PET 2021 conference [rescheduled] Sep 25, 2021 - Sep 27, 2021 — McEwan Hall, University of Edinburgh

eLearning

SINAPSE experts from around Scotland have developed ten online modules designed to explain medical imaging. They are freely available and are intended for non-specialists.


Edinburgh Imaging Academy at the University of Edinburgh offers the following online programmes through a virtual learning environment:

Neuroimaging for Research MSc/Dip/Cert

Imaging MSc/Dip/Cert

PET-MR Principles & Applications Cert

Applied Medical Image Analysis Cert

Online Short Courses

Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial

Author(s): Jackie F. Price, Marlene C. Stewart, Ian J. Deary, Gordon D. Murray, Peter Sandercock, Isabella Butcher, F. Gerald R. Fowkes

Abstract:
Objective To determine the effects of tow dose aspirin on cognitive function in middle aged to elderly men and women at moderately increased cardiovascular risk.Design Randomised double blind placebo controlled trial.Setting Central Scotland.Participants 3350 men and women aged over 50 participating in the aspirin for asymptomatic atherosclerosis trial.Intervention Low dose aspirin (100 mg daily) or placebo for five years.Main outcome measures Tests of memory, executive function, non-verbal reasoning, mental flexibility, and information processing five years after randomisation, with test scores used to create a summary cognitive score (general factor).Results At baseline, mean vocabulary scores (an indicator of previous cognitive ability) were similar in the aspirin (30.9, SD 4.7) and placebo (31.1, SD 4.7) groups. In the primary intention to treat analysis, there was no significant difference at follow-up between the groups in the proportion achieving over the median general factor cognitive score (32.7% and 34.8% respectively, odds ratio 0.91, 95% confidence interval 0.79 to 1.05, P=0.20) or in mean scores on the individual cognitive tests. There were also no significant differences in change in cognitive ability over the five years in a subset of 504 who underwent detailed cognitive testing at baseline.Conclusion Low dose aspirin does not affect cognitive function in middle aged to elderly people at moderately increased cardiovascular risk.Trial registration ISRCTN 66587262.

Full version: Available here

Click the link to go to an external website with the full version of the paper


ISBN: 0959-8146(print)|0959-535x(electronic)
Publication Year: 2008
Periodical: Bmj
Periodical Number: 7669
Volume: 337
Pages:
Author Address: